CN4171505
Active
Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)
$317.7M
Contract Value
Contract Details
- Contract ID
- CN4171505
- Status
- active
- Financial Year
- FY26
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Key Dates
- Publish Date
- 18 July 2025
- Signed Date
- 18 July 2025
- Start Date
- 30 June 2025
- End Date
- 29 June 2028
- Duration
- 3 years, 1 month
Procurement Information
- Procurement Method
- Limited tender
- Exemption Code
- TR
- Exemption Reason
- 10.3.d.iii. Supply by particular business: due to an absence of competition for technical reasons.
Supplier
ROCHE PRODUCTS PTY LTD
- ABN
- 70 000 132 865
- Entity Type
- Australian Private Company
- Location
- NSW